image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
S-8
Filing Date
March 15, 2023
Document Date
March 15, 2023
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC
Print Page
RSS Feeds
Email Alerts
Search